Sign in

CIK 0000727510

  • Non-accelerated filer
  • Smaller reporting company

Viskase Holdings, Inc.

Sign in to watch
Ticker
VISK
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222372868
Phone
+1 630-874-0700
Business address
333 EAST BUTTERFIELD ROAD, SUITE 400, LOMBARD, IL, 60148
Former names
ENZON PHARMACEUTICALS, INC., ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICALS INC, ENZON PHARMACEUTICAL INC, ENZON INC
  1. 4 Shares withheld for taxes COO and Princ. Exec. Officer gave up 11,546 shares (to pay taxes)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Shares withheld for taxes EVP, R&D, CSO gave up 1,063 shares (to pay taxes)
  10. 4 Shares withheld for taxes COO and Princ. Exec. Officer gave up 1,417 shares (to pay taxes)
  11. 4 Shares withheld for taxes Exec. Vice Pres. HR gave up 1,181 shares (to pay taxes)
  12. 4 Grant or award COO and Principal Exec Officer acquired 15,000 shares (grant or award)
  13. 4 Grant or award EVP, President of R&D and CSO acquired 15,000 shares (grant or award)
  14. 4 Grant or award Exec. Vice Pres. HR acquired 8,000 shares (grant or award)
  15. 4 Open-market sale EVP, R&D, CSO sold 258,900 shares at an average $10.67 ($2,762,992)
  16. 4 Shares withheld for taxes EVP, R&D, CSO gave up 7,084 shares (to pay taxes)
  17. 4 Open-market sale Director sold 10,000 shares at an average $10.49 ($104,929)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Grant or award Director acquired 14,086 shares (grant or award)
  20. 4 Grant or award Director acquired 7,043 shares (grant or award)

Page 7 of 28 · 560 filings